A Clinical Trial on the Failure Rates of Metallic and Ceramic Orthodontic Brackets

Sponsor
University of Pavia (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05151991
Collaborator
(none)
100
1
2
14
7.2

Study Details

Study Description

Brief Summary

The aim of this study is to assess if there are significant differences in the failure rate of stainless steel and ceramic brackets. For this study, patients will be enrolled and divided into two groups, according to the type of brackets (stainless steel or ceramic) used for orthodontic treatment. Failure rates will be recorded every month for 12 months and survival analysis will be performed, together with skeletal and space analysis.

Condition or Disease Intervention/Treatment Phase
  • Other: Fixed orthodontic treatment with stainless steel brackets
  • Other: Fixed orthodontic treatment with ceramic brackets
N/A

Detailed Description

This clinical trial aims to investigate if there are differences in the failure rates of stainless steel and ceramic orthodontic brackets. Patients willing to start orthodontic fixed therapy and recruited for the study will be asked to sign the informed consent. Parents will sign the consent for underage patients. After that, patients will be divided into two groups:

  • Group MET: stainless steel brackets will be bonded on the vestibular surfaces of teeth.

  • Group CER: ceramic brackets will be bonded on the vestibular surfaces of teeth. The following sequence of archwires will be adopted for the first six months: 0.014-in Niti, .016-in NiTi, 0.017X0.025-in NiTi, 0.019X0.025-in SS. The failure rates of the brackets will be recorded each month for 12 months. Each failed bracket will be recorded once. For each patient, pre-treatment lateral cephalometric radiograph and study models will be used to measure ANB angle, Wits, Skeletal Class, dento-alveolar discrepancy and Little Index at the beginning of the treatment. Bond failures will be recorded together with the archwire engaged at the moment of the failure.

Sample size Sample size was calculated with the following assumptions: ability to detect a clinically relevant difference of 5.12% in the failure rates (primary outcome) of the two groups with an alfa = 0.05 and power = 85%. The assumptions were based on findings of a previous study with an expected value of 12.08% for the first group at the end of 12 months of therapy. Therefore, 1000 brackets (50 patients) per group were required for the study.

Statistical analysis Statistical analysis will be conducted with R software (R version 3.1.3, R Development Core Team, R Foundation for Statistical Computing, Wien, Austria). Fisher exact test will be performed to evaluate the differences between the failure rates of the two groups, between anterior and posterior sites and between upper and lower arches. Kaplan-Meier survival analysis of the bond failures will be performed among the 12 months of the study. Linear regressions will be calculated to assess the effects on bond failure of the skeletal and dental variables collected before the bonding procedure. Significance for all statistical tests will be predetermined at P<0.05.

Study Design

Study Type:
Interventional
Actual Enrollment :
100 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Diagnostic
Official Title:
A 12-months Evaluation of the Failure Rates of Stainless Steel and Ceramic Brackets in Orthodontic Fixed Therapy: a Clinical Trial.
Actual Study Start Date :
Dec 9, 2021
Anticipated Primary Completion Date :
Feb 5, 2023
Anticipated Study Completion Date :
Feb 7, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Groups MET

Patients from this group will undergo orthodontic fixed treatment with stainless steel brackets.

Other: Fixed orthodontic treatment with stainless steel brackets
Orthophosphoric acid 37% acid (Gerhò Etchant gel 37%, Gerhò spa, Terlano, Italy) will be applied for 30 s for the etching of the vestibular surfaces of teeth. The, after rinsing and drying, a thin layer of Transbond XT Light Cure Adhesive Primer (3M Unitek, Monrovia, CA, USA) will be applied and then cured for 10 s with a LED unit. At last, Transbond XT Light Cure Adhesive Paste (3M Unitek) will be applied on the base of stainless steel brackets (Queen Series Low Profile Brackets MBT 0.022", Aestetika, Terni, TR, Italy); brackets will be applied on the vestibular surfaces of teeth with a light pressure and the extra paste will be removed. Curing will be performed with the LED unit at 2 mm distant from the enamel-bracket interface for 40 s, 10 s per each surface (mesial, distal, gingival and occlusal). Then, the following sequence of archwires will be adopted for the first six months: .014-in Niti, .016-in NiTi, .017X.025-in NiTi, .019X.025-in SS (Aestetika, Terni, Italy).

Active Comparator: Group CER

Patients from this group will undergo orthodontic fixed treatment with ceramic brackets.

Other: Fixed orthodontic treatment with ceramic brackets
Orthophosphoric acid 37% (acid (Gerhò Etchant gel 37%, Gerhò spa, Terlano, Italy) will be applied for 30 s for the etching of the vestibular surfaces of teeth. The, after rinsing and drying, a thin layer of Transbond XT Light Cure Adhesive Primer (3M Unitek, Monrovia, CA, USA) will be applied and then cured for 10 s with a LED unit. At last, Transbond XT Light Cure Adhesive Paste (3M Unitek) will be applied on the base of ceramic brackets; brackets (Super Clear Series Brackets MBT 0.022", Aestetika, Terni, TR, Italy) will be applied on the vestibular surfaces of teeth with a light pressure and the extra paste is removed. Curing will be performed with the LED unit at 2 mm distant from the enamel-bracket interface for 40 s, 10 s per each surface (mesial, distal, gingival and occlusal). Then, the following sequence of archwires will be adopted for the first six months: .014-in Niti, .016-in NiTi; .017X.025-in NiTi, .019X.025-in SS (Aestetika, Terni, Italy).

Outcome Measures

Primary Outcome Measures

  1. Failure rates of metallic and ceramic brackets. [Among the 12 months of the study.]

    Each month, failed brackets will be recorded. Per each tooth, failure will be recorded once.

Secondary Outcome Measures

  1. Failure rates of metallic and ceramic brackets per sites and sides. [Among the 12 months of the study.]

    Failures will be divided in "anterior" for brackets failed on incisors and canines, and "posterior" for premolar brackets. Failure will be recorded per dental arch ("upper" and "lower") and per archwire (.014-in NiTi, .016-in NiTi, .017X0.25-in NiTi, .019X.025-in SS). Per each tooth, failure will be recorded once.

  2. ANB angle [Before the beginning of the orthodontic treatment.]

    ANB angle will be calculated using the pre-treatment lateral cephalometric radiograph.

  3. Wits Index [Before the beginning of the orthodontic treatment.]

    Wits Index will be calculated using the pre-treatment lateral cephalometric radiograph.

  4. Skeletal Class [Before the beginning of the orthodontic treatment.]

    Skeletal Class will be assessed using ANB angle and Wits Index will be calculated using the pre-treatment lateral cephalometric radiograph.

  5. Dento-alveolar discrepancy [Before the beginning of the orthodontic treatment.]

    Dento-alveolar discrepancy will be calculated using the pre-treatment study models.

  6. Little Index [Before the beginning of the orthodontic treatment.]

    Little Index will be calculated using the pre-treatment study models.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients willing to begin fixed multibracket therapy with metallic or ceramic brackets;

  • full permanent dentition;

  • enamel integrity, absence of traumatic or carious lesions, no pretreatment procedure performed with chemical agents;

  • no previous orthodontic treatment with fixed vestibular appliances.

Exclusion Criteria:
  • patients suffering from systemic diseases;

  • patients taking medications that could alter periodontal conditions (NSAIDS, steroids, etc.);

  • patients with low compliance;

  • patients unable to give informed consent;

  • presence of congenital enamel defects;

  • extractions for orthodontic reasons;

  • oral/orthognathic surgery.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Unit of Orthodontics and Pediatric Dentistry - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Pediatrics - University of Pavia Pavia Lombardy Italy 27100

Sponsors and Collaborators

  • University of Pavia

Investigators

  • Principal Investigator: Andrea Scribante, DDS, PhD, University of Pavia

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Andrea Scribante, Research Resident, Principal Investigator, University of Pavia
ClinicalTrials.gov Identifier:
NCT05151991
Other Study ID Numbers:
  • 2021-METCERORTO
First Posted:
Dec 9, 2021
Last Update Posted:
Feb 11, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Andrea Scribante, Research Resident, Principal Investigator, University of Pavia
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 11, 2022